On March 1, 2024 NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, reported the company will participate in the upcoming TD Cowen 44th Annual Health Care Conference in Boston, Massachusetts (Press release, NeoGenomics Laboratories, MAR 1, 2024, View Source [SID1234640712]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Members of NeoGenomics’ management team will participate in a fireside chat on Tuesday, March 5th at 9:10 a.m. ET. A live and archived audio webcast of the presentation will be available on the "News, Events, and Webcasts" tab via the Investor Relations section of the Company’s website at ir.neogenomics.com.